A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Status:
Terminated
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This is a Phase IV, open label, case-controlled, observational study to evaluate the
age-adjusted cumulative height velocity in pre-pubertal isolated growth hormone deficient
(IGHD) and idiopathic short stature (ISS) participants receiving daily doses of somatropin
(recombinant human growth hormone [rhGH]; Nutropin) using NuSpin device compared to
historical controls from the national cooperative growth study (NCGS).